Compound ID | 1322
Spectrum of activity: | Gram-positive |
Institute where first reported: | Department of Pharmaceutical Science and Research, School of Pharmacy, and Department of Biomedical Sciences, Joan C. Edwards School of Medicine, Marshall University, Huntington, West Virginia, USA |
Year first mentioned: | 2017 |
Highest developmental phase: | Preclinical |
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/3117 and https://pubchem.ncbi.nlm.nih.gov/compound/5455 |
DrugBank link: | https://www.drugbank.ca/drugs/DB00822 |
Citations: |
|